# ClinicalTrials.gov record NCT03139305

> PeptideScanner retained ClinicalTrials.gov record NCT03139305 at 2026-07-30T16:22:22.326Z. Its registry update date was 2026-03-30, and PeptideScanner's reviewed identity mapping was glucagon.

- Evidence object: `story:clinicaltrials-gov-nct03139305-glucagon:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-03-30
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03139305-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03139305-glucagon-v1.json
- Content SHA-256: `c70ab2ed16c648ba5adb2e62598f84ad80e230cf4b761b32f35509fbe310b2d4`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT03139305 ([`ctg-observation-nct03139305-2026-03-30-010ee1e3a13f`](#source-ctg-observation-nct03139305-2026-03-30-010ee1e3a13f))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03139305 at 2026-07-30T16:22:22.326Z. Its registry update date was 2026-03-30, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct03139305-2026-03-30-010ee1e3a13f`](#source-ctg-observation-nct03139305-2026-03-30-010ee1e3a13f))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03139305 at 2026-07-30T16:22:22.326Z. Its registry update date was 2026-03-30, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct03139305-2026-03-30-010ee1e3a13f`](#source-ctg-observation-nct03139305-2026-03-30-010ee1e3a13f))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03139305-2026-03-30-010ee1e3a13f`](#source-ctg-observation-nct03139305-2026-03-30-010ee1e3a13f))

## Sources

<a id="source-ctg-observation-nct03139305-2026-03-30-010ee1e3a13f"></a>
- **ClinicalTrials.gov record NCT03139305 · retained source version 2026-03-30:010ee1e3a13fd80a9ba6f09e53a36fcb11124b06fa8e131f0c31a45211b3ecb2** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03139305) (`ctg-observation-nct03139305-2026-03-30-010ee1e3a13f`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03139305." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03139305-glucagon-v1.json SHA-256: c70ab2ed16c648ba5adb2e62598f84ad80e230cf4b761b32f35509fbe310b2d4.